ImageneBio (IMA) Other Non-Current Liabilities (2023 - 2025)

ImageneBio has disclosed Other Non-Current Liabilities across 3 years of filings, most recently posting $870000.0 for Q4 2025.

• Other Non-Current Liabilities for Q4 2025 came in at $870000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $870000.0 (changed N/A YoY), and the FY2025 annual result was $870000.0, changed N/A from the prior year.
• Other Non-Current Liabilities came in at $870000.0 for Q4 2025 at ImageneBio, down from $1.1 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $1.1 million in Q3 2025 to a low of $870000.0 in Q4 2025.
• The 3-year median for Other Non-Current Liabilities is $1.0 million (2024), against an average of $1.0 million.
• Peak annual rise in Other Non-Current Liabilities reached 11.72% in 2025, while the deepest fall reached 5.71% in 2025.
• ImageneBio's Other Non-Current Liabilities stood at $950000.0 in 2023, then gained by 10.0% to $1.0 million in 2024, then dropped by 16.75% to $870000.0 in 2025.
• The last three Other Non-Current Liabilities figures came in at $870000.0 (Q4 2025), $1.1 million (Q3 2025), and $1.1 million (Q2 2025), per Business Quant data.